Nonprofits: A Growing Force in Drug Development

Therapeutic development involves several stakeholders across the science ecosystem—academic institutions, biotechnology and pharmaceutical companies, regulatory authorities, investors, philanthropic funders, and nonprofit organizations—each playing a critical role in advancing a drug from discovery to market.

In the Nonprofits: A Growing Force in Drug Development report, SPARC explores the diverse strategies employed by nonprofits to facilitate the translational drug development process and expand therapeutic options for patients, identifying common obstacles, examining the timing and contexts in which these models are most effective, and highlighting how nonprofits can leverage their unique approaches and financial mechanisms to overcome these challenges.